* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
4233	MET	C2239176	Liver carcinoma	0.618363628410326	BEFREE;CTD_human;HPO;LHGDN;UNIPROT
4233	MET	C1306837	Papillary Renal Cell Carcinoma	0.402747267842131	BEFREE;HPO;ORPHANET
4233	MET	C0027627	Neoplasm Metastasis	0.23292414797362	BEFREE;CTD_human;LHGDN
4233	MET	C0001418	Adenocarcinoma	0.230929283597542	BEFREE;CTD_human;LHGDN
4233	MET	C0007131	Non-Small Cell Lung Carcinoma	0.22747267842131	BEFREE;CTD_human
4233	MET	C0004352	Autistic Disorder	0.218614230060237	BEFREE;CTD_human;GAD;LHGDN
4233	MET	C0024121	Lung Neoplasms	0.218045835494161	BEFREE;CTD_human;LHGDN
4233	MET	C0007134	Renal Cell Carcinoma	0.214257082024447	BEFREE;CTD_human;LHGDN
4233	MET	C0017636	Glioblastoma	0.210425262422781	BEFREE;CTD_human;LHGDN
4233	MET	C0007137	Squamous cell carcinoma	0.209861453477037	BEFREE;CTD_human;LHGDN
4233	MET	C0029463	Osteosarcoma	0.207938365987545	BEFREE;CTD_human;LHGDN
4233	MET	C0038356	Stomach Neoplasms	0.204381273170092	BEFREE;CTD_human;LHGDN
4233	MET	C0036341	Schizophrenia	0.202956482091714	BEFREE;CTD_human;GAD
4233	MET	C0919267	ovarian neoplasm	0.202732912464814	CTD_human;LHGDN
4233	MET	C0037199	Sinusitis	0.202407028523288	CTD_human;GAD
4233	MET	C0345967	Malignant mesothelioma	0.201098907136852	BEFREE;CTD_human
4233	MET	C0004114	Astrocytoma	0.200824180352639	BEFREE;CTD_human
4233	MET	C0023467	Leukemia, Myelocytic, Acute	0.200824180352639	BEFREE;CTD_human
4233	MET	C0014859	Esophageal Neoplasms	0.200549453568426	BEFREE;CTD_human
4233	MET	C1336839	Type 1 Papillary Renal Cell Carcinoma	0.200274726784213	BEFREE;UNIPROT
4233	MET	C4084709	DEAFNESS, AUTOSOMAL RECESSIVE 97	0.2	UNIPROT
4233	MET	C1861901	Subacute progressive viral hepatitis	0.2	HPO
4233	MET	C1862761	Increased hepatocellular carcinoma risk	0.2	HPO
4233	MET	C1867955	Increased incidence of hepatocellular carcinoma	0.2	HPO
4233	MET	C1876165	Copper-Overload Cirrhosis	0.2	CTD_human
4233	MET	C2931899	Papillary renal cell carcinoma, familial	0.2	ORPHANET
4233	MET	C0009241	Cognition Disorders	0.2	CTD_human
4233	MET	C0019189	Hepatitis, Chronic	0.2	CTD_human
4233	MET	C0023904	Liver Neoplasms, Experimental	0.2	CTD_human
4233	MET	C0027626	Neoplasm Invasiveness	0.2	CTD_human
4233	MET	C0027819	Neuroblastoma	0.2	CTD_human
4233	MET	C0267812	Micronodular cirrhosis	0.2	HPO
4233	MET	C0544886	Somatic mutation	0.2	HPO
4233	MET	C0006142	Malignant neoplasm of breast	0.0896154374474585	BEFREE;MGD
4233	MET	C0040517	Gilles de la Tourette syndrome	0.08	MGD
4233	MET	C1970243	AUTISM, SUSCEPTIBILITY TO, 9	0.08	MGD
4233	MET	C0242379	Malignant neoplasm of lung	0.026111721145938	BEFREE;GAD
4233	MET	C0009404	Colorectal Neoplasms	0.0196798408221225	BEFREE;LHGDN
4233	MET	C0699791	Stomach Carcinoma	0.0151099731317205	BEFREE
4233	MET	C0684249	Carcinoma of lung	0.0140110659948681	BEFREE
4233	MET	C1306460	Primary malignant neoplasm of lung	0.0134616124264419	BEFREE
4233	MET	C0024623	Malignant neoplasm of stomach	0.0131868856422288	BEFREE
4233	MET	C0268621	Hepatic methionine adenosyltransferase deficiency	0.0126374320738026	BEFREE
4233	MET	C0596263	Carcinogenesis	0.0120879785053764	BEFREE
4233	MET	C0033578	Prostatic Neoplasms	0.0114811034276812	BEFREE;LHGDN
4233	MET	C0149925	Small cell carcinoma of lung	0.0109460052365723	BEFREE;LHGDN
4233	MET	C0678222	Breast Carcinoma	0.0093407106632454	BEFREE
4233	MET	C1458155	Mammary Neoplasms	0.00902291774708056	BEFREE;LHGDN
4233	MET	C1527249	Colorectal Cancer	0.0079670767421799	BEFREE
4233	MET	C0009402	Colorectal Carcinoma	0.0076923499579668	BEFREE
4233	MET	C0035412	Rhabdomyosarcoma	0.006839458850693	BEFREE;LHGDN
4233	MET	C0178874	Tumor Progression	0.0065934428211144	BEFREE
4233	MET	C0017638	Glioma	0.00657908744379715	BEFREE;LHGDN
4233	MET	C0206698	Cholangiocarcinoma	0.0060152784980537	BEFREE;LHGDN
4233	MET	C0026764	Multiple Myeloma	0.00575490709115785	BEFREE;LHGDN
4233	MET	C0001430	Adenoma	0.0057405517138406	BEFREE;LHGDN
4233	MET	C0030297	Pancreatic Neoplasm	0.00541466777231485	BEFREE;GAD;LHGDN
4233	MET	C0010674	Cystic Fibrosis	0.0046703553316227	BEFREE
4233	MET	C0023903	Liver neoplasms	0.00438127317009235	BEFREE;LHGDN
4233	MET	C1261473	Sarcoma	0.00438127317009235	BEFREE;LHGDN
4233	MET	C0025202	melanoma	0.0041209017631965	BEFREE
4233	MET	C0376358	Malignant neoplasm of prostate	0.0038461749789834	BEFREE
4233	MET	C0600139	Prostate carcinoma	0.0038461749789834	BEFREE
4233	MET	C0879257	Hereditary Papillary Renal Carcinoma	0.0038461749789834	BEFREE
4233	MET	C0007133	Carcinoma, Papillary	0.00383181960166615	BEFREE;LHGDN
4233	MET	C1510586	Autism Spectrum Disorders	0.0035714481947703	BEFREE
4233	MET	C0152013	Adenocarcinoma of lung (disorder)	0.0032967214105572	BEFREE
4233	MET	C0280100	solid tumor	0.0032967214105572	BEFREE
4233	MET	C0024299	Lymphoma	0.00328236603323995	BEFREE;LHGDN
4233	MET	C0029925	Ovarian Carcinoma	0.0030219946263441	BEFREE
4233	MET	C0023493	Adult T-Cell Lymphoma/Leukemia	0.00300763924902685	BEFREE;LHGDN
4233	MET	C0040136	Thyroid Neoplasm	0.00300763924902685	BEFREE;LHGDN
4233	MET	C0005684	Malignant neoplasm of urinary bladder	0.0029564820917142	BEFREE;GAD
4233	MET	C0278996	Cancer of Head and Neck	0.0029564820917142	BEFREE;GAD
4233	MET	C0007102	Malignant tumor of colon	0.002747267842131	BEFREE
4233	MET	C0399440	Hereditary gingival fibromatosis	0.002747267842131	BEFREE
4233	MET	C0699790	Colon Carcinoma	0.002747267842131	BEFREE
4233	MET	C1959632	Plasma Cell Neoplasm	0.00273291246481375	LHGDN
4233	MET	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	0.00273291246481375	LHGDN
4233	MET	C0002736	Amyotrophic Lateral Sclerosis	0.00273291246481375	LHGDN
4233	MET	C0007124	Noninfiltrating Intraductal Carcinoma	0.00273291246481375	LHGDN
4233	MET	C0009375	Colonic Neoplasms	0.00273291246481375	LHGDN
4233	MET	C0013990	Pathological accumulation of air in tissues	0.00273291246481375	LHGDN
4233	MET	C0014170	Endometrial Neoplasms	0.00273291246481375	LHGDN
4233	MET	C0015695	Fatty Liver	0.00273291246481375	LHGDN
4233	MET	C0024236	Lymphedema	0.00273291246481375	LHGDN
4233	MET	C0025568	Metaplasia	0.00273291246481375	LHGDN
4233	MET	C0027697	Nephritis	0.00273291246481375	LHGDN
4233	MET	C0029295	Oropharyngeal Neoplasms	0.00273291246481375	LHGDN
4233	MET	C0034150	Purpura	0.00273291246481375	LHGDN
4233	MET	C0036421	Systemic Scleroderma	0.00273291246481375	LHGDN
4233	MET	C0037299	Skin Ulcer	0.00273291246481375	LHGDN
4233	MET	C0027430	Nasal Polyps	0.0026817553075011	BEFREE;GAD
4233	MET	C0740457	Malignant neoplasm of kidney	0.0024725410579179	BEFREE
4233	MET	C0007621	Neoplastic Cell Transformation	0.002407028523288	GAD
4233	MET	C0020503	Hyperparathyroidism, Secondary	0.002407028523288	GAD
4233	MET	C0024117	Chronic Obstructive Airway Disease	0.002407028523288	GAD
4233	MET	C0027092	Myopia	0.002407028523288	GAD
4233	MET	C0034951	Refractive Errors	0.002407028523288	GAD
4233	MET	C0035455	Rhinitis	0.002407028523288	GAD
4233	MET	C0553723	Squamous cell carcinoma of skin	0.002407028523288	GAD
4233	MET	C0085281	Addictive Behavior	0.0021978142737048	BEFREE
4233	MET	C0686619	Secondary malignant neoplasm of lymph node	0.0021978142737048	BEFREE
4233	MET	C1378703	Renal carcinoma	0.0021978142737048	BEFREE
4233	MET	C1140680	Malignant neoplasm of ovary	0.0021978142737048	BEFREE
4233	MET	C1621958	Glioblastoma Multiforme	0.0019230874894917	BEFREE
4233	MET	C0235974	Pancreatic carcinoma	0.0019230874894917	BEFREE
4233	MET	C0238463	Papillary thyroid carcinoma	0.0019230874894917	BEFREE
4233	MET	C0346647	Malignant neoplasm of pancreas	0.0019230874894917	BEFREE
4233	MET	C0022665	Kidney Neoplasm	0.0016483607052786	BEFREE
4233	MET	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	0.0016483607052786	BEFREE
4233	MET	C0585442	Osteosarcoma of bone	0.0016483607052786	BEFREE
4233	MET	C1168401	Squamous cell carcinoma of the head and neck	0.0016483607052786	BEFREE
4233	MET	C0812413	Malignant Pleural Mesothelioma	0.0013736339210655	BEFREE
4233	MET	C2931822	Nasopharyngeal carcinoma	0.0013736339210655	BEFREE
4233	MET	C0025149	Medulloblastoma	0.0013736339210655	BEFREE
4233	MET	C0025500	Mesothelioma	0.0013736339210655	BEFREE
4233	MET	C0279628	Adenocarcinoma Of Esophagus	0.0013736339210655	BEFREE
4233	MET	C0524528	Pervasive Development Disorder	0.0013736339210655	BEFREE
4233	MET	C0549473	Thyroid carcinoma	0.0013736339210655	BEFREE
4233	MET	C0006118	Brain Neoplasms	0.0010989071368524	BEFREE
4233	MET	C0008487	Chordoma	0.0010989071368524	BEFREE
4233	MET	C0153690	Secondary malignant neoplasm of bone	0.0010989071368524	BEFREE
4233	MET	C0546837	Malignant neoplasm of esophagus	0.0010989071368524	BEFREE
4233	MET	C1290375	Mesothelioma (malignant, clinical disorder) (disorder)	0.0010989071368524	BEFREE
4233	MET	C0948380	Colorectal cancer metastatic	0.0008241803526393	BEFREE
4233	MET	C1512409	Hepatocarcinogenesis	0.0008241803526393	BEFREE
4233	MET	C1709246	Non-Neoplastic Disorder	0.0008241803526393	BEFREE
4233	MET	C0677886	Epithelial ovarian cancer	0.0008241803526393	BEFREE
4233	MET	C1112160	Gastrooesophageal cancer	0.0008241803526393	BEFREE
4233	MET	C0005695	Bladder Neoplasm	0.0008241803526393	BEFREE
4233	MET	C0019829	Hodgkin Disease	0.0008241803526393	BEFREE
4233	MET	C0153676	Secondary malignant neoplasm of lung	0.0008241803526393	BEFREE
4233	MET	C0206681	Adenocarcinoma, Clear Cell	0.0008241803526393	BEFREE
4233	MET	C0238462	Medullary carcinoma of thyroid	0.0008241803526393	BEFREE
4233	MET	C0278488	Carcinoma breast stage IV	0.0008241803526393	BEFREE
4233	MET	C0279626	Squamous cell carcinoma of esophagus	0.0008241803526393	BEFREE
4233	MET	C0332996	Persistent embryonic structure	0.0008241803526393	BEFREE
4233	MET	C0494165	Secondary malignant neoplasm of liver	0.0008241803526393	BEFREE
4233	MET	C0555198	Malignant Glioma	0.0008241803526393	BEFREE
4233	MET	C0005967	Bone neoplasms	0.0005494535684262	BEFREE
4233	MET	C0007120	Bronchioloalveolar Adenocarcinoma	0.0005494535684262	BEFREE
4233	MET	C0007135	Adenocarcinoma, Scirrhous	0.0005494535684262	BEFREE
4233	MET	C0024232	Lymphatic Metastasis	0.0005494535684262	BEFREE
4233	MET	C0027051	Myocardial Infarction	0.0005494535684262	BEFREE
4233	MET	C0039101	synovial sarcoma	0.0005494535684262	BEFREE
4233	MET	C0041107	Trisomy	0.0005494535684262	BEFREE
4233	MET	C0079744	Diffuse Large B-Cell Lymphoma	0.0005494535684262	BEFREE
4233	MET	C0085612	Ventricular arrhythmia	0.0005494535684262	BEFREE
4233	MET	C0152018	Esophageal carcinoma	0.0005494535684262	BEFREE
4233	MET	C0206651	Sarcoma, Clear Cell	0.0005494535684262	BEFREE
4233	MET	C0206654	Leiomyomatosis	0.0005494535684262	BEFREE
4233	MET	C0220633	Uveal melanoma	0.0005494535684262	BEFREE
4233	MET	C0238198	Gastrointestinal Stromal Tumors	0.0005494535684262	BEFREE
4233	MET	C0345904	Malignant neoplasm of liver	0.0005494535684262	BEFREE
4233	MET	C0346010	Multiple fibrofolliculomas	0.0005494535684262	BEFREE
4233	MET	C0346429	Multiple malignancy	0.0005494535684262	BEFREE
4233	MET	C0521158	Recurrent tumor	0.0005494535684262	BEFREE
4233	MET	C1519670	Tumor Angiogenesis	0.0005494535684262	BEFREE
4233	MET	C1518693	Ovarian Clear Cell Adenocarcinoma	0.0005494535684262	BEFREE
4233	MET	C1704272	Benign Prostatic Hyperplasia	0.0005494535684262	BEFREE
4233	MET	C1510472	Drug Dependence	0.0005494535684262	BEFREE
4233	MET	C3899716	Canine Osteosarcoma	0.0005494535684262	BEFREE
4233	MET	C2608055	Hereditary Renal Cell Carcinoma	0.0005494535684262	BEFREE
4233	MET	C1368683	Epithelioma	0.0005494535684262	BEFREE
4233	MET	C1334274	Invasive Carcinoma	0.0005494535684262	BEFREE
4233	MET	C0677936	Refractory cancer	0.0005494535684262	BEFREE
4233	MET	C0854917	Rhabdoid Tumor of the Kidney	0.0005494535684262	BEFREE
4233	MET	C0699885	Carcinoma of bladder	0.0005494535684262	BEFREE
4233	MET	C4048328	cervical cancer	0.0002747267842131	BEFREE
4233	MET	C0677607	Hashimoto Disease	0.0002747267842131	BEFREE
4233	MET	C0853879	Invasive carcinoma of breast	0.0002747267842131	BEFREE
4233	MET	C0796070	MICROPHTHALMIA, SYNDROMIC 7	0.0002747267842131	BEFREE
4233	MET	C1883486	Uterine Corpus Cancer	0.0002747267842131	BEFREE
4233	MET	C0751690	Malignant Peripheral Nerve Sheath Tumor	0.0002747267842131	BEFREE
4233	MET	C0751688	Malignant Squamous Cell Neoplasm	0.0002747267842131	BEFREE
4233	MET	C0751396	Well Differentiated Oligodendroglioma	0.0002747267842131	BEFREE
4233	MET	C2145472	Urothelial Carcinoma	0.0002747267842131	BEFREE
4233	MET	C0741899	Poorly differentiated carcinoma	0.0002747267842131	BEFREE
4233	MET	C2316810	Chronic kidney disease stage 5	0.0002747267842131	BEFREE
4233	MET	C0677898	invasive cancer	0.0002747267842131	BEFREE
4233	MET	C0699753	Cancer Relapse	0.0002747267842131	BEFREE
4233	MET	C0854985	Adenocarcinoma of lung, stage I	0.0002747267842131	BEFREE
4233	MET	C3273239	Proliferative Inflammatory Atrophy	0.0002747267842131	BEFREE
4233	MET	C3463824	MYELODYSPLASTIC SYNDROME	0.0002747267842131	BEFREE
4233	MET	C3539878	Triple Negative Breast Neoplasms	0.0002747267842131	BEFREE
4233	MET	C3539909	Allergic disposition	0.0002747267842131	BEFREE
4233	MET	C3642347	Basal-Like Breast Carcinoma	0.0002747267842131	BEFREE
4233	MET	C3714524	Fibromyxosarcoma	0.0002747267842131	BEFREE
4233	MET	C3826590	Chest--Tumors	0.0002747267842131	BEFREE
4233	MET	C3888194	MIXED LINEAGE LEUKEMIA	0.0002747267842131	BEFREE
4233	MET	C1512981	Mammary Tumorigenesis	0.0002747267842131	BEFREE
4233	MET	C1333064	Classical Hodgkin's Lymphoma	0.0002747267842131	BEFREE
4233	MET	C1334708	Metaplastic breast carcinoma	0.0002747267842131	BEFREE
4233	MET	C1334720	Metastatic Malignant Peripheral Nerve Sheath Tumor	0.0002747267842131	BEFREE
4233	MET	C1332922	Cervical Squamous Intraepithelial Neoplasia	0.0002747267842131	BEFREE
4233	MET	C1337013	Differentiated Thyroid Gland Carcinoma	0.0002747267842131	BEFREE
4233	MET	C1318558	Congenital melanocytic nevus	0.0002747267842131	BEFREE
4233	MET	C1302401	Adenoma of large intestine	0.0002747267842131	BEFREE
4233	MET	C1292753	Primary Effusion Lymphoma	0.0002747267842131	BEFREE
4233	MET	C1282496	Metastasis from malignant tumor of prostate	0.0002747267842131	BEFREE
4233	MET	C1275122	Familial multiple trichoepitheliomata	0.0002747267842131	BEFREE
4233	MET	C1269683	Major Depressive Disorder	0.0002747267842131	BEFREE
4233	MET	C1333600	Hereditary Malignant Neoplasm	0.0002747267842131	BEFREE
4233	MET	C1266127	Histiocytoma, Angiomatoid Fibrous	0.0002747267842131	BEFREE
4233	MET	C1266119	Solitary fibrous tumor	0.0002747267842131	BEFREE
4233	MET	C1168327	High-Grade Prostatic Intraepithelial Neoplasia	0.0002747267842131	BEFREE
4233	MET	C0948780	Rhinosinusitis	0.0002747267842131	BEFREE
4233	MET	C1623038	Cirrhosis	0.0002747267842131	BEFREE
4233	MET	C1658953	tumor vasculature	0.0002747267842131	BEFREE
4233	MET	C0948216	ovarian adenocarcinoma	0.0002747267842131	BEFREE
4233	MET	C0936223	Metastatic Prostate Carcinoma	0.0002747267842131	BEFREE
4233	MET	C1709353	Osteofibrous Dysplasia	0.0002747267842131	BEFREE
4233	MET	C1833970	COLORECTAL CANCER, SOMATIC	0.0002747267842131	BEFREE
4233	MET	C1839259	Bulbo-Spinal Atrophy, X-Linked	0.0002747267842131	BEFREE
4233	MET	C0001125	Acidosis, Lactic	0.0002747267842131	BEFREE
4233	MET	C0002395	Alzheimer's Disease	0.0002747267842131	BEFREE
4233	MET	C0002871	Anemia	0.0002747267842131	BEFREE
4233	MET	C0003504	Aortic Valve Insufficiency	0.0002747267842131	BEFREE
4233	MET	C0003873	Rheumatoid Arthritis	0.0002747267842131	BEFREE
4233	MET	C0004096	Asthma	0.0002747267842131	BEFREE
4233	MET	C0005694	Bladder neck obstruction	0.0002747267842131	BEFREE
4233	MET	C0006413	Burkitt Lymphoma	0.0002747267842131	BEFREE
4233	MET	C0007103	Malignant neoplasm of endometrium	0.0002747267842131	BEFREE
4233	MET	C0007115	Malignant neoplasm of thyroid	0.0002747267842131	BEFREE
4233	MET	C0007138	Carcinoma, Transitional Cell	0.0002747267842131	BEFREE
4233	MET	C0007140	Carcinosarcoma	0.0002747267842131	BEFREE
4233	MET	C0007847	Malignant tumor of cervix	0.0002747267842131	BEFREE
4233	MET	C0008479	Chondrosarcoma	0.0002747267842131	BEFREE
4233	MET	C0009324	Ulcerative Colitis	0.0002747267842131	BEFREE
4233	MET	C0011570	Mental Depression	0.0002747267842131	BEFREE
4233	MET	C0011581	Depressive disorder	0.0002747267842131	BEFREE
4233	MET	C0014175	Endometriosis	0.0002747267842131	BEFREE
4233	MET	C0016057	Fibrosarcoma	0.0002747267842131	BEFREE
4233	MET	C0017150	Gastrinoma	0.0002747267842131	BEFREE
4233	MET	C0017152	Gastritis	0.0002747267842131	BEFREE
4233	MET	C0017525	Giant Cell Tumors	0.0002747267842131	BEFREE
4233	MET	C0018799	Heart Diseases	0.0002747267842131	BEFREE
4233	MET	C0018923	Hemangiosarcoma	0.0002747267842131	BEFREE
4233	MET	C0019196	Hepatitis C	0.0002747267842131	BEFREE
4233	MET	C0019562	Von Hippel-Lindau Syndrome	0.0002747267842131	BEFREE
4233	MET	C0021051	Immunologic Deficiency Syndromes	0.0002747267842131	BEFREE
4233	MET	C0021670	insulinoma	0.0002747267842131	BEFREE
4233	MET	C0022661	Kidney Failure, Chronic	0.0002747267842131	BEFREE
4233	MET	C0023418	leukemia	0.0002747267842131	BEFREE
4233	MET	C0023434	Chronic Lymphocytic Leukemia	0.0002747267842131	BEFREE
4233	MET	C0023470	Myeloid Leukemia	0.0002747267842131	BEFREE
4233	MET	C0023492	Leukemia, T-Cell	0.0002747267842131	BEFREE
4233	MET	C0023530	Leukopenia	0.0002747267842131	BEFREE
4233	MET	C0023890	Liver Cirrhosis	0.0002747267842131	BEFREE
4233	MET	C0025209	Melanosis	0.0002747267842131	BEFREE
4233	MET	C0026010	Microphthalmos	0.0002747267842131	BEFREE
4233	MET	C0026470	Monoclonal Gammopathy of Undetermined Significance	0.0002747267842131	BEFREE
4233	MET	C0026691	Mucocutaneous Lymph Node Syndrome	0.0002747267842131	BEFREE
4233	MET	C0027708	Nephroblastoma	0.0002747267842131	BEFREE
4233	MET	C0027859	Acoustic Neuroma	0.0002747267842131	BEFREE
4233	MET	C0027947	Neutropenia	0.0002747267842131	BEFREE
4233	MET	C0028945	oligodendroglioma	0.0002747267842131	BEFREE
4233	MET	C0029408	Degenerative polyarthritis	0.0002747267842131	BEFREE
4233	MET	C0030552	Paresis	0.0002747267842131	BEFREE
4233	MET	C0031039	Pericardial effusion	0.0002747267842131	BEFREE
4233	MET	C0032463	Polycythemia Vera	0.0002747267842131	BEFREE
4233	MET	C0032580	Adenomatous Polyposis Coli	0.0002747267842131	BEFREE
4233	MET	C0032927	Precancerous Conditions	0.0002747267842131	BEFREE
4233	MET	C0035372	Rett Syndrome	0.0002747267842131	BEFREE
4233	MET	C0037579	Soft Tissue Neoplasms	0.0002747267842131	BEFREE
4233	MET	C0038358	Gastric ulcer	0.0002747267842131	BEFREE
4233	MET	C0040100	Thymoma	0.0002747267842131	BEFREE
4233	MET	C0041696	Unipolar Depression	0.0002747267842131	BEFREE
4233	MET	C0042510	Ventricular Fibrillation	0.0002747267842131	BEFREE
4233	MET	C0042514	Tachycardia, Ventricular	0.0002747267842131	BEFREE
4233	MET	C0042769	Virus Diseases	0.0002747267842131	BEFREE
4233	MET	C0043346	Xeroderma Pigmentosum	0.0002747267842131	BEFREE
4233	MET	C0043515	Zollinger-Ellison syndrome	0.0002747267842131	BEFREE
4233	MET	C0079772	T-Cell Lymphoma	0.0002747267842131	BEFREE
4233	MET	C0085605	Liver Failure	0.0002747267842131	BEFREE
4233	MET	C0149516	Chronic sinusitis	0.0002747267842131	BEFREE
4233	MET	C0149782	Squamous cell carcinoma of lung	0.0002747267842131	BEFREE
4233	MET	C0151514	Atrophic condition of skin	0.0002747267842131	BEFREE
4233	MET	C0151650	Renal fibrosis	0.0002747267842131	BEFREE
4233	MET	C0151786	Muscle Weakness	0.0002747267842131	BEFREE
4233	MET	C0162557	Liver Failure, Acute	0.0002747267842131	BEFREE
4233	MET	C0162670	Mitochondrial Myopathies	0.0002747267842131	BEFREE
4233	MET	C0175754	Agenesis of corpus callosum	0.0002747267842131	BEFREE
4233	MET	C0205696	Anaplastic carcinoma	0.0002747267842131	BEFREE
4233	MET	C0205824	Liposarcoma, Dedifferentiated	0.0002747267842131	BEFREE
4233	MET	C0206093	Neuroectodermal Tumors	0.0002747267842131	BEFREE
4233	MET	C0206655	Alveolar rhabdomyosarcoma	0.0002747267842131	BEFREE
4233	MET	C0206657	Alveolar Soft Part Sarcoma	0.0002747267842131	BEFREE
4233	MET	C0206686	Adrenocortical carcinoma	0.0002747267842131	BEFREE
4233	MET	C0206703	Carcinoma, Giant Cell	0.0002747267842131	BEFREE
4233	MET	C0206704	Carcinoma, Large Cell	0.0002747267842131	BEFREE
4233	MET	C0206708	Cervical Intraepithelial Neoplasia	0.0002747267842131	BEFREE
4233	MET	C0206754	Neuroendocrine Tumors	0.0002747267842131	BEFREE
4233	MET	C0220636	Malignant neoplasm of salivary gland	0.0002747267842131	BEFREE
4233	MET	C0220647	Carcinoma of unknown primary	0.0002747267842131	BEFREE
4233	MET	C0220650	Metastatic malignant neoplasm to brain	0.0002747267842131	BEFREE
4233	MET	C0221391	Melanosis coli	0.0002747267842131	BEFREE
4233	MET	C0238461	Anaplastic thyroid carcinoma	0.0002747267842131	BEFREE
4233	MET	C0260037	Multiple tumors	0.0002747267842131	BEFREE
4233	MET	C0265264	Holt-Oram syndrome	0.0002747267842131	BEFREE
4233	MET	C0265783	Congenital hypoplasia of lung	0.0002747267842131	BEFREE
4233	MET	C0278498	Malignant neoplasm of stomach stage IV	0.0002747267842131	BEFREE
4233	MET	C0278512	Metastatic osteosarcoma	0.0002747267842131	BEFREE
4233	MET	C0278701	Gastric Adenocarcinoma	0.0002747267842131	BEFREE
4233	MET	C0278987	Non-small cell lung cancer metastatic	0.0002747267842131	BEFREE
4233	MET	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	0.0002747267842131	BEFREE
4233	MET	C0279751	Adenoid cystic carcinoma of salivary gland	0.0002747267842131	BEFREE
4233	MET	C0280280	stage, prostate cancer	0.0002747267842131	BEFREE
4233	MET	C0280313	Squamous cell carcinoma of oropharynx	0.0002747267842131	BEFREE
4233	MET	C0280317	Tonsillar Squamous Cell Carcinoma	0.0002747267842131	BEFREE
4233	MET	C0282160	Aplasia Cutis Congenita	0.0002747267842131	BEFREE
4233	MET	C0282612	Prostatic Intraepithelial Neoplasias	0.0002747267842131	BEFREE
4233	MET	C0302592	Cervix carcinoma	0.0002747267842131	BEFREE
4233	MET	C0311361	Adenomatous goiter	0.0002747267842131	BEFREE
4233	MET	C0333293	Healing ulcer	0.0002747267842131	BEFREE
4233	MET	C0334317	Cystadenofibroma	0.0002747267842131	BEFREE
4233	MET	C0334663	Histiocytic sarcoma	0.0002747267842131	BEFREE
4233	MET	C0339543	Epiretinal Membrane	0.0002747267842131	BEFREE
4233	MET	C0345964	Adenoma of lung	0.0002747267842131	BEFREE
4233	MET	C0346990	Carcinomatosis of peritoneal cavity	0.0002747267842131	BEFREE
4233	MET	C0349788	Arrhythmogenic Right Ventricular Dysplasia	0.0002747267842131	BEFREE
4233	MET	C0376544	Hematopoietic Neoplasms	0.0002747267842131	BEFREE
4233	MET	C0476089	Endometrial Carcinoma	0.0002747267842131	BEFREE
4233	MET	C0520679	Sleep Apnea, Obstructive	0.0002747267842131	BEFREE
4233	MET	C0553580	Ewings sarcoma	0.0002747267842131	BEFREE
4233	MET	C0598935	Tumor Initiation	0.0002747267842131	BEFREE